SCHEMBL4827209

SCHEMBL4827209

ClCn1cnnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28609350 0.79
SCHEMBL2534570 0.72
Ammonia Solution, Strong SCHEMBL28914391 0.72
SCHEMBL29061272 0.70
SCHEMBL19755650 0.69 ALDH1A1 (0.62)
SCHEMBL28611936 0.69
SCHEMBL15932248 0.67 MEN1 (0.54)
SCHEMBL9733403 0.67
SCHEMBL18675284 0.67
SCHEMBL22255955 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171563-B1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2025-08-06 EP disclosed
US-20250092019-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2025-03-20 US disclosed
EP-4228755-B1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-12-11 EP disclosed
WO-2024240882-A1 HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR USE IN TREATING ACUTE INFLAMMATION TES PHARMA S.R.L. (IT) 2024-11-28 WO disclosed
EP-4171571-B1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-10-30 EP disclosed
US-20240352033-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-10-24 US disclosed
US-20240352032-A1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-10-24 US disclosed
EP-4228756-B1 TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-06-12 EP disclosed
CN-114945408-B Thienopyrimidinones as TRPA1 inhibitors 勃林格殷格翰国际有限公司 2024-04-16 CN disclosed
US-11891403-B2 Tetrazole derivatives as TRPA1 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-02-06 US disclosed
CN-103724330-B The effective combined utilization of monobactams antibiotic and beta-lactamase inhibitor BASLIER PHARMACEUTICAL AG (CH) 2015-08-19 CN disclosed
CN-100503602-C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them DONGBU HANNONG CHEMICAL CO LTD (KR) 2009-06-24 CN disclosed
US-20080071091-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES WYETH (US) 2008-03-20 US disclosed
US-7323483-B2 Processes and compounds for the preparation of substituted naphthylindole derivatives WYETH (US) 2008-01-29 US disclosed
CN-101111491-A Process and compounds for the preparation of substituted naphthylindole derivatives WYETH CORP (US) 2008-01-23 CN disclosed
EP-1856104-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES Wyeth a Corporation of the State of Delaware (US) 2007-11-21 EP disclosed
US-20060183917-A1 Processes and compounds for the preparation of substituted naphthylindole derivatives WYETH (US) 2006-08-17 US disclosed
WO-2006081455-A1 PROCESSES AND COMPOUNDS FOR THE PREPARATION OF SUBSTITUTED NAPHTHYLINDOLE DERIVATIVES WYETH (US) 2006-08-03 WO disclosed
CN-1646524-A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them DONGBU HANNONG CHEMICAL CO LTD (KR) 2005-07-27 CN disclosed
US-4277479-A ANTI-ASTHMATIC, HYPOTENSIVE, ANTI-ULCER, ANTIINFLAMMATORY, VASODILATION, ENZYME INHIBITORS, ANTICOAGULANTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1981-07-07 US disclosed